Sequencing

11th Annual Sequencing, Finishing, and Analysis in the Future Meeting
SEQUENCING PANEL ROUND TABLE
Sponsored by Swift Bio
16:00 – 17:00
Speaker 1: Maryke Appel (Roche Diagnostics Corporation)
The Roche Sequencing Story: Driving toward personalized medicine
Routine sequencing has the potential to revolutionize healthcare, especially in the
areas of Oncology, Infectious Diseases and Prenatal Testing, and help realize the
potential of personalized medicine. Roche Sequencing’s long‐term goals are to become
the partner of choice for next‐generation sequencing (NGS), and make NGS a routine
clinical practice. To achieve this, we are working toward solutions that are truly
transformative. Our core strategy comprises a phased approach to building simplified,
end‐to‐end (sample in, result out) workflows. To this end, Roche has acquired best‐inclass
technologies across the whole workflow—from Sample Preparation through
Sequencing, Analysis and Reporting.
In this presentation, we will provide a high‐level overview of our vision, technology
pipeline and focus on cell‐free DNA as a key clinical sample type.
Speaker 2: Jeremy Preston (illumina)
Illumina sequencing technology updates and application in the microbial
world
Illumina has been at the forefront of the genomics revolution with the development of
a suite of sequencing technologies ranging from ultra‐high throughput to low cost,
bench top machines. This presentation will introduce Illumina’s portfolio of sequencing
systems with a focus on our new, low cost, easy to use bench top solutions and will
summarize key findings in seminal publications using Illumina technology.
Speaker 3: Steve Turner (PacBio)
PacBio sequencing technology update and applications
25